vimarsana.com

Page 46 - நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Scandion Oncology engages former ASCO executive as clinical advisor

Scandion Oncology engages former ASCO executive as clinical advisor Scandion Oncology is pleased to announce that we have appointed Dr. Richard L. Schilsky, a seasoned and highly profiled international leader as a member of our clinical advisory board (CAB). Dr. Schilsky is the former CMO and Executive Vice President of the American Society of Clinical Oncology (ASCO) and a long-time faculty member of the University of Chicago. Scandion Oncology A/S Publicerad: 21 april 2021, 11:30 Copenhagen, April 21, 2021. Scandion Oncology, The Cancer Drug Resistance Company, is pleased to announce that Richard L. Schilsky, MD, FACP, FSCT, FASCO has accepted to join the clinical advisory board of Scandion Oncology.

Africa Energy Closes Farmouts on Block 2B Offshore South Africa

Africa Energy Closes Farmouts on Block 2B Offshore South Africa News provided by Share this article VANCOUVER, BC, April 20, 2021 /CNW/ -  Africa Energy Corp. (TSXV: AFE) (Nasdaq First North: AEC) ( Africa Energy or the Company ), an oil and gas company with exploration assets offshore South Africa and Namibia, has received governmental approval and closed the previously announced farmout transactions on Block 2B offshore South Africa. The Company has transferred operatorship and an aggregate 62.5% participating interest in the Exploration Right for Block 2B in consideration for a carry through the next exploration well, Gazania-1, which is expected to spud by the end of 2021. Africa Energy retains a 27.5% participating interest in Block 2B. View PDF version.

Nasdaq Stockholm AB: The observation status for ArcAroma AB is updated (173/21)

Nasdaq Stockholm AB: The observation status for ArcAroma AB is updated (173/21) On January 20, 2021, the shares in ArcAroma AB ( ArcAroma ) were given observation status with reference to an adopted merger plan between ArcAroma and OptiFreeze AB ( Optifreeze ), according to which ArcAroma will be absorbed by OptiFreeze. Today, April 20, 2021, ArcAroma applied for delisting of its shares from Nasdaq First North Growth Market. The rules of Nasdaq First North Growth Market state that an issuer may be given observation status if the issuer has applied to have its financial instruments removed from Nasdaq First North Growth Market. With reference to the above, Nasdaq Stockholm AB decides to update the

Investegate |Nexstim Oyj Announcements | Nexstim Oyj: Correction to the Invitation to the Annual General Meeting of Nexstim Plc

Investegate |Nexstim Oyj Announcements | Nexstim Oyj: Correction to the Invitation to the Annual General Meeting of Nexstim Plc
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.